Biochemical basis of the pharmacologic action of chondroitin sulfates on the osteoarticular system

Seminars in Arthritis and Rheumatism

Volumn 31, Issue 1, 2001, Pages 58-68

  Bali, Jean Pierre ^a   Cousse, Henri ^a   Neuzil, Eugegravene ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Articular diseases; Bone; Cartilage; Chondrocytes; Chondroitin sulfates; Mineralization; Proteoglycans

Indexed keywords

AGGRECAN; CALCIUM; CHONDROITIN SULFATE; GLYCOSAMINOGLYCAN; GLYCOSYLTRANSFERASE; LYSOSOME ENZYME; MATRIX METALLOPROTEINASE; PROTEINASE; PROTEOGLYCAN;

APOPTOSIS; ARTHROPATHY; ARTICLE; BIOSYNTHESIS; BONE METABOLISM; BONE MINERALIZATION; BONE REMODELING; CALCIUM HOMEOSTASIS; CARTILAGE CELL; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG STRUCTURE; DRUG TOLERABILITY; GLYCOSAMINOGLYCAN METABOLISM; HUMAN; JOINT DEGENERATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SYNOVIAL FLUID; TREATMENT OUTCOME;

EID: 0034892525     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1053/sarh.2000.24874     Document Type: Article

References (65)

1. Pharmacodynamic characteristics of low-molecular weight dermatan sulphate after subcutaneous administration of acute myocardial infarction
2. Intramuscular dermatan sulphate MF701 in patients with hip fracture: Relationship between pharmacokinetics and antithrombotic properties
3. Les traitements antiarthrosiques: Efficacité et tolérance des chondroitine sulfates
4. Chondroitine sulfates (CS 4&6): Applications pratiques et impact économique
5. Chondroitin sulphate and joint disease
6. Nutraceuticals as therapeutic agents in osteoarthritis. The role of glucosamine, chondroitin sulphate, and collagen hydrolysates
7. Le chondroitine sulphate dans le traitement de la gonarthrose et de la coxarthrose
8. Roles of aggrecan, a large chondroitin sulphate proteoglycan, in cartilage structure and function
9. Sulfation of chondroitin sulphate in human articular cartilage. The effect of age, topographical position, and zone of cartilage on tissue composition
10. Proteoglycans of adult bovine compact bone
11. Comparison of chondroitin sulphate composition of femoral head articular cartilage from patients with femoral neck fractures and osteoarthritis and controls
12. Cartilage
13. Proteoglycan core protein families
14. L'eau, une molécule trés particulière
15. Extracellular matrix/growth factors interactions
16. Current topics in the biosynthesis, structure and function of collagen
17. Proteoglycan biosynthesis
18. Structure and metabolism of proteoglycans
19. Structure and biology of proteoglycans
20. Intracellular membranes in the biosynthesis, transport, and metabolism of proteoglycans
21. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation
22. Mechanisms of proteoglycan metabolism that lead to cartilage destruction in the pathogenesis of arthhritis
23. Identification of a stromelysin cleavage site within the interglobular domain of human aggrecan. Evidence for proteolysis at this site in vivo in human articular cartilage
24. Neutrophil collagenase (MMP-8) cleaves at the aggrecanase site E373-A374 in the interglobular domain of cartilage aggrecan
25. 374 bond of the interglobular domain
26. The structure of aggrecan fragments in human synovial fluid. Evidence that aggrecanase mediates cartilage degradation in inflammatory joint disease, joint injury and osteoarthritis
27. Purification and cloning of aggrecanase-1: A member of the ADAMTS family of proteins
28. Rapport d'expertise pharmacologique de la spécialité pharmaceutique LG 337 (dénomination provisoire)
29. A low-sulfated chondroitin sulphate in rat blood: An acidic glycosaminoglycan with a high metabolic rate
30. Biochemical and pharmacokinetic aspects of oral treatment with chondroitin sulphate
31. Anti-inflammatory activity of chondroitin sulphate
32. Interaction between human leukocyte elastase and chondroitin sulphate
33. Expériences pharmacologiques sur l'efficacité anti-phlogistique de chondroitine sulfurique (Structum®)
34. Interactions of the chymotrypsin- and elastase-like enzymes of the human granulocytes with glycosaminoglycans
35. Cathepsin B secretion by rabbit articular chondrocytes: Modulation by cycloheximide and glycosaminoglycans
36. In vitro evaluation of drugs proposed as chondroprotective agents
37. Effects of chondroitin sulphate and interleukin-1α on human articular chondrocytes cultivated in clusters
38. Modulation of cyclic AMP-dependent protein kinase by derivatives of chondroitin sulphate
39. Chondroitin sulphate and derivatives as hydroxyl radical scavengers
40. Stimulation of chondroitin sulphate proteoglycan production by chondrocytes in monolayer
41. Influence of sulfated glycosaminoglycans upon proteoglycan metabolism of the synovial lining cells
42. Influences of sulfated glycosaminoglycans on biosynthesis of hyaluronic acid in rabbit knee synovial membranes
43. Structural determinants of the capacity of heparin to inhibit collagen synthesis in 21-day fetal rat calvariae
44. Effect of one compound Structum® on cytokines secretion by human macrophages and PBMC
45. Levels of chondroitin sulphate isomers in synovial fluid of patient with hip osteoarthritis
46. Chondroitin sulfation patterns in synovial fluid in osteoarthritis subsets
47. Apoptose des chondrocytes articularies. Mécanisme et protection
48. Intrinsic viscosity calculated out of single point measurements for chondroitin-4-sulphate and chondroitin-6-sulphate solutions
49. Effects of chondroitin sulphate-C on bradykinin-induced proteoglycan depletion in rats
50. Effects of oral and intramuscular use of chondroitin sulphate in induced equine aseptic arthritis
51. New experimental results on cartilage destruction and protection
52. Essai clinique contrôle du Structum comparativement à l'acide acetylsalicylique dans les espèces canines et félines arthrosiques
53. Effets de l'ACS sur l'ostóporose chez les personnes agées
54. 35S] sulphate into glycosaminoglycans by mineralized tissues in vivo
55. Immunoelectron microscopic analysis of chondroitin sulfates during calcification in the rat growth plate cartilage
56. Exogenous glycosaminoglycans (GAG) differentially modulate GAG synthesis by anchorage-independent culture of the outer cells from neonatal rat calvaria in the absence and presence of TGFβ
57. Chondroitin sulphate inhibits calcification of bone formed in vitro
58. The effect of glycosaminoglycans on the mineralization of sheep periodontal ligament in vitro
59. Ultrastructural and immunocytochemical study of bone-derived cell cultures in three-dimensional matrices: Influence of chondroitin-4-sulphate on mineralization
60. Role of chondroitin sulphate glycosaminoglycans in mineralizing osteoblast-like cells: Effect of hormonal manipulation
61. Heparin-induced osteoporosis in rats
62. Multiple fractures associated with long-term sodium heparin therapy
63. Effects of heparin on osteoclast activity
64. Glycosaminoglycan stimulation of calcium release from mouse calvariae. Specificity for hyaluronic acid and dermatan sulphate
65. Chondroitin-3-sulfate. The structure of a sulfated 1c4s